Human Genome Epidemiology Literature Finder
Records 1 - 20 (of 20 Records) |
Query Trace: Adenocarcinoma and MUT[original query] |
---|
Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in Chinese patients. Lung cancer (Amsterdam, Netherlands) 2014 Nov 86 (2): 164-9. Chao Liu, Yi-Sheng Huang, Yu Chen, Li-Xu Yan, Xin-Lan Luo, Dong-Lan Luo, Jie Chen, Yi-Lon Wu, Hui Liu Y |
The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2014 Sep 9 (9): 1363-9. Izar Benjamin, Zhou Haiyu, Heist Rebecca S, Azzoli Christopher G, Muzikansky Alona, Scribner Emily E F, Bernardo Lindsay A, Dias-Santagata Dora, Iafrate Anthony J, Lanuti Micha |
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1. Molecular cancer 2018 Apr 17 (1): 81. Liu Liang, Ruiz Jimmy, O'Neill Stacey S, Grant Stefan C, Petty W Jeffrey, Yang Meng, Chen Kexin, Topaloglu Umit, Pasche Boris, Zhang W |
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy. The oncologist 2019 5 24 (10): 1340-1347. Parikh Aparna R, He Yuting, Hong Ted S, Corcoran Ryan B, Clark Jeff W, Ryan David P, Zou Lee, Ting David T, Catenacci Daniel V, Chao Joseph, Fakih Marwan, Klempner Samuel J, Ross Jeffrey S, Frampton Garrett M, Miller Vincent A, Ali Siraj M, Schrock Alexa |
Traditional Serrated Pathway-associated Colorectal Carcinoma: Morphologic Reappraisal of Serrated Morphology, Tumor Budding, and Identification of Frequent PTEN Alterations. The American journal of surgical pathology 2019 May . Tsai Jia-Huei, Jeng Yung-Ming, Yuan Chang-Tsu, Lin Yu-Lin, Cheng Mei-Ling, Liau Jau- |
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 4 25 (15): 4712-4722. Benayed Ryma, Offin Michael, Mullaney Kerry, Sukhadia Purvil, Rios Kelly, Desmeules Patrice, Ptashkin Ryan, Won Helen, Chang Jason, Halpenny Darragh, Schram Alison M, Rudin Charles M, Hyman David M, Arcila Maria E, Berger Michael F, Zehir Ahmet, Kris Mark G, Drilon Alexander, Ladanyi Ma |
Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma. Journal of cancer research and clinical oncology 2020 Aug . Wang Feng, Zhao Ning, Gao Ge, Deng Hong-Bin, Wang Zhi-Hui, Deng Li-Li, Yang Yu, Lu Changli |
TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Mar . Sinn Marianne, Sinn Bruno V, Treue Denise, Keilholz Ulrich, Damm Frederik, Schmuck Rosa, Lohneis Philipp, Klauschen Frederick, Striefler Jana K, Bahra Marcus, Bläker Hendrik, Bischoff Sven, Pelzer Uwe, Oettle Helmut, Riess Hanno, Budczies Jan, Denkert Carst |
EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma. Aging 2020 Dec 12 . Chen Zhiming, Chen Ji, Ren Dandan, Zhang Jiao, Yang Ying, Zhang Henghui, Mao Beibei, Ma Hait |
The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses. Aging 2020 Dec 12 . Zhou Pei, Wu Xueying, Chen Huan, Hu Ying, Zhang Henghui, Wu Lijia, Yang Ying, Mao Beibei, Wang Huaqi |
The mutational pattern of homologous recombination (HR)-associated genes and its relevance to the immunotherapeutic response in gastric cancer. Cancer biology & medicine 2020 Nov 17 (4): 1002-1013. Fan Yue, Ying Haifeng, Wu Xueying, Chen Huan, Hu Ying, Zhang Henghui, Wu Lijia, Yang Ying, Mao Beibei, Zheng L |
Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma. ESMO open 2020 11 5 (6): e000942. Seeber Andreas, Zimmer Kai, Kocher Florian, Puccini Alberto, Xiu Joanne, Nabhan Chadi, Elliott Andrew, Goldberg Richard M, Grothey Axel, Shields Anthony F, Battaglin Francesca, El-Deiry Wafik S, Philip Philip A, Marshall John L, Hall Michael, Korn W Michael, Lenz Heinz-Josef, Wolf Dominik, Feistritzer Clemens, Spizzo Gilbe |
Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung. Thoracic cancer 2021 8 12 (20): 2789-2795. Zhang Shuyang, Yin Huihui, Zhang Jing, Yang Lu, Yang Guangjian, Jia Jia, Jiao Yuchen, Ying Jianming, Wang Y |
Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer patients. Translational lung cancer research 2021 3 10 (2): 826-838. Fung Andrea S, Karimi Maryam, Michiels Stefan, Seymour Lesley, Brambilla Elisabeth, Le-Chevalier Thierry, Soria Jean-Charles, Kratzke Robert, Graziano Stephen L, Devarakonda Siddhartha, Govindan Ramaswamy, Tsao Ming-Sound, Shepherd Frances |
Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma. Frontiers in oncology 2021 11 11 771247. Jiang Jiahong, Xu Yaping, Chang Lianpeng, Ru Guoqing, Xia Xuefeng, Yang Ling, Yi Xin, Chen Zheling, Huang Dong-Sheng, Yang L |
Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC. BMC medicine 2021 10 19 (1): 239. Sun Yiting, Duan Jianchun, Fang Wenfeng, Wang Zhijie, Du Xinyang, Wang Xin, Li Chengcheng, Cai Shangli, Zhao Jie, Li Sini, Zhang Li, Bai Hua, Wang J |
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Jun . Lee Keun-Wook, Van Cutsem Eric, Bang Yung-Jue, Fuchs Charles S, Kudaba Iveta, Garrido Marcelo, Chung Hyun Cheol, Lee Jeeyun, Castro Hugo R, Chao Joseph, Wainberg Zev A, Cao Z Alexander, Aurora-Garg Deepti, Kobie Julie, Cristescu Razvan, Bhagia Pooja, Shah Sukrut, Tabernero Josep, Shitara Kohei, Wyrwicz Lucj |
Retrospective Survival Analysis of Patients With Advanced Pancreatic Ductal Adenocarcinoma and Germline BRCA or PALB2 Mutations. JCO precision oncology 2022 2 2 1-9. Reiss Kim A, Yu Shun, Judy Renae, Symecko Heather, Nathanson Katherine L, Domchek Susan |
B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis. Journal of inflammation research 2022 15 5541-5555. Lin Anqi, Fang Jianbo, Cheng Quan, Liu Zaoqu, Luo Peng, Zhang Ji |
Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma. Frontiers in oncology 2023 7 13 1169586. Prashanth Ashok Kumar, Serenella Serinelli, Daniel J Zaccarini, Richard Huang, Natalie Danziger, Tyler Janovitz, Alina Basnet, Abirami Sivapiragasam, Stephen Graziano, Jeffrey S Ro |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: